Metoprolol - drug sheet PDF

Title	Metoprolol - drug sheet
Author	Katherine Mentzer
Course	Fundamentals Of Nursing
Institution	LaGuardia Community College
Pages	2
File Size	110.9 KB
File Type	PDF
Total Downloads	3
Total Views	134

Preview

CLICK TO PREVIEW PDF

Summary

drug sheet...

Description

Bristol Community College NUR 101 Medication Sheet

Medication & Classification 1. 2. 3. 4. 5. 6.

Name of drug (trade/generic) Dosage R/A All times due All classifications Safe dose

1. Generic: Metoprolol tartrate

Medications administered on your time 1.Drug Action 1.

List the most common side effects/adverse reactions

2.Reason pt. is on medication. (Be specific)

2.

1. Pharmacodynamics:

I. Most common side effects/adverse reactions

Trade: Lopressor Pharmacokinetics: Onset: 15 minutes

List all significant nursing actions related to the administration of med to this patient and number them.

CNS: fatigue, weakness CV: BRADYCARDIA, HF, PULMONARY EDEMA

2. Dosage: Peak: unknown 3. Route of Administration: PO

Duration: 6-12hrs

Absorption: Well absorbed after oral 4. Scheduled times:

5. Classifications: Beta-blockers Therapeutic: Antianginals, antihypertensives

6. Safe dose:

7. Is this medication a HIGH ALERT drug? Yes

8. Is this medication a “Look alike/sound alike” drug? High Alert: Do not confuse Toprol-XL (metoprolol succinate) with Topamax (topiramate). Do not confuse Lopressor (metoprolol tartrate) with Lyrica (pregabalin). Do not confuse metoprolol tartrate with metoprolol succinate.

administration.

Distribution: Crosses the bloodbrain barrier, crosses the placenta; small amounts enter breast milk. Metabolism: Mostly metabolized by the liver (primarily by CYP2D6; the CYP2D6 enzyme system exhibits genetic polymorphism); Genetic implication ~7% of population may be poor metabolizers and may have significantly ↑ metoprolol concentrations and an ↑ risk of adverse effects.

Excretion: not listed 2. Reason patient is on med.

II. Nursing actions: A. Assessment: 1. Monitor BP, ECG, and pulse frequently during dose adjustment and periodically during therapy. 2.Monitor frequency of prescription refills to determine compliance. 3.Monitor vital signs and ECG every 5–15 min during and for several hrs after parenteral administration. If heart rate...